Although the sample size was substantial for a trial in AML (320 patients, 236 AML relapses, 196 deaths), the trial was insufficiently powered to detect an effect on OS and did not reach statistical significance on the OS endpoint.
← all excerpts
Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.
1
—
—